© Supplied by CNBCTV18 Astrazeneca will get promoting authorisation to use ant-diabetic issues drug for kidney illness Drug business AstraZeneca...
Disorder
The MarketWatch Information Section was not involved in the development of this content material. Jan 30, 2021 (Market place Perception...
